跳至主要内容
临床试验/ACTRN12608000078358
ACTRN12608000078358已完成3 期

A randomised controlled study on Healthy Individuals to evaluate the efficacy of glyco-nutrient therapy compared to placebo on antioxidant and various immune cell functions with end of study outcomes.

Mannatech, Inc0 个研究点目标入组 60 人开始时间: 2008年2月13日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Individuals willing to cease all medications over the course of the study, excluding medications for acute conditions such as pain or dyspepsia.

排除标准

  • Individuals taking antioxidant medications and/or supplements. Individuals with poor venous access. Individuals with auto-immune disorders or an immune disease. Individuals taking steroid medication or non steroidal anti-inflammatory drugs (NSAID) treatments. Individuals with diabetes. Individuals taking anticoagulants. Individuals taking immune suppressant drugs. Individuals taking cytokine or interferon therapy. Individuals taking Echinacea or other immune stimulating herbs. Individuals with clinically abnormal liver function tests at baseline. Individuals who develop a cold or other acute upper respiratory tract infection (URTI) or influenza during the course of the study. Individuals unwilling to have blood taken 6 times during the study. Individuals unwilling to comply with the study protocols. Individuals with any other condition which in the opinion of the researchers could compromise the study.

研究者

发起方
Mannatech, Inc

相似试验